INVESTOR ALERT: Pomerantz Law Firm Investigates Claims 0n Behalf of Investors of Globus Medical, Inc. - GMED
1. Pomerantz LLP is investigating potential securities fraud at Globus Medical. 2. Globus Medical's Q1 2025 earnings missed estimates, impacting stock price significantly. 3. The company's revenue declined year-over-year by 1.4%, raising investor concerns. 4. Stock fell nearly 23% following the disappointing earnings announcement. 5. Investors have been advised to join the class action against the company.